There were 844 press releases posted in the last 24 hours and 183,942 in the last 365 days.

Naloxone Spray Global Market To Grow At Rate Of 22% Through 2025

Naloxone Spray Global Market Report 2021 : COVID-19 Implications And Growth

Naloxone Spray Market Report 2021 : COVID-19 Implications And Growth

The Business Research Company’s Naloxone Spray Global Market Report 2021 : COVID-19 Implications And Growth

LONDON, GREATER LONDON , UK, October 6, 2021 /EINPresswire.com/ -- According to the new market research report ‘Naloxone Spray Global Market Report 2021: COVID-19 Implications And Growth’ published by The Business Research Company, the naloxone spray market is expected to grow from $285.09 million in 2020 to $351.39 million in 2021 at a compound annual growth rate (CAGR) of 23.3%. The change in growth trend of the naloxone spray market is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The naloxone spray market is expected to reach $785.35 million in 2025 at a CAGR of 22.3%. The increasing prevalence of opioid overdoses drives the growth of the naloxone spray market.

Request For A Sample For The Global Naloxone Spray Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5339&type=smp

The naloxone spray market consists of sales of naloxone spray by entities (organizations, sole traders, and partnerships) – the product is prefilled with naloxone, and a needle-free device is sprayed into one nostril, and it requires no assembly. It is used for treating opioid emergencies with symptoms such as problems with breathing and severe sleepiness or inability to respond. Naloxone is a non-scheduled prescription drug which belongs to the class of medications called opiate antagonists, and is used to reverse or prevent the effects of opioid narcotic overdose for drugs such as codeine, fentanyl, morphine, and oxycodone. Naloxone comes as a solution (liquid) to spray into the nose and each naloxone nasal spray contains a single dose of naloxone and should be used only once.

Trends In The Global Naloxone Spray Market
The increase in product approvals is shaping the naloxone spray market. Major companies manufacturing naloxone sprays are focused on new product approvals to broaden their product portfolios and expand their naloxone spray business. For instance, in April 2021, the US Food and Drug Administration (FDA) approved Hikma Pharmaceuticals KLOXXADOTM (naloxone hydrochloride) nasal spray 8 mg for the immediate treatment of recognized or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression, in adult and pediatric patients. KLOXXADOTM provides an important new treatment to address the opioid epidemic and contains twice as much naloxone per spray as Narcan Nasal Spray 4mg in a ready-to-use nasal spray to reverse the effects of opioid overdose.

Global Naloxone Spray Market Segments:
The global naloxone spray market is further segmented:
By Dosage: 2 mg/Actuation, 4 mg/Actuation
By Distribution Channel: Hospitals, Clinics, Retail Pharmacies, Online Pharmacies, Others
By Geography: The global naloxone spray market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, the North American naloxone spray global market accounts for the largest share in the global naloxone spray market.

Read More On The Report For The Global Naloxone Spray Market At:
https://www.thebusinessresearchcompany.com/report/naloxone-spray-global-market-report

Naloxone Spray Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides naloxone spray global market overviews, analyzes and forecasts market size and growth for the global naloxone spray market, naloxone spray global market share, naloxone spray global market players, naloxone spray global market segments and geographies, naloxone spray market’s leading competitors’ revenues, profiles and market shares. The naloxone spray global market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Read Naloxone Spray Global Market Report 2021 from The Business Research Company for information on the following:

Data Segmentations: Market Size, Global, By Region And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries

Naloxone Spray Market Organizations Covered: Emergent BioSolutions, Pfizer, Teva Pharmaceutical Industries Ltd., Opiant Pharmaceuticals, Hikma Pharmaceuticals, Nasus Pharma, Amphastar Pharmaceuticals, Indivior PLC, Samarth Pharma Pvt. Ltd., Troikaa Pharmaceuticals Ltd., and Neon Laboratories Limited.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Interested to know more about The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Get a quick glimpse of our services here: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Here is a list of reports from The Business Research Company similar to the Naloxone Spray Global Market Report 2021:

Pharmaceutical Drugs Global Market Report 2021 - By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorders Drugs, Musculoskeletal Disorders Drugs, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Respiratory Diseases Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs), COVID-19 Impact And Recovery
https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-global-market-report

Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Intravenous, Intranasal/ Inhalation), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Over-The-Counter Drugs, Prescription-Based Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/central-nervous-system-drugs-global-market

Neurostimulation Devices Global Market Report 2021 - By Product (Implantable Devices, External Devices), By Application (Pain Management, Epilepsy, Essential Tremor, Urinary And Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson's Disease), By End User (Hospitals, Rehabilitation Centers, Medical Clinic), By Implantable Devices (Cochlear Implants, Deep Brain Stimulation, Spinal Cord Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric Electric Stimulation), By External Devices (Transcranial Magnetic Stimulation (TMS), Transcutaneous Electrical Nerve Stimulation (TENS)), COVID-19 Impact And Recovery
https://www.thebusinessresearchcompany.com/report/neurostimulation-devices-global-market-report

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

The Business Research Company
Email: info@tbrc.info
Follow us on LinkedIn: https://bit.ly/3b7850r
Follow us on Twitter: https://bit.ly/3b1rmjS
Check out our Blog: http://blog.tbrc.info/

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn